share_log

海翔药业(002099.SZ):回购完成 累计耗资1.51亿元回购3147.85万股

Haixiang Pharmaceutical (002099.SZ): The repurchase was completed with a cumulative cost of 151 million yuan to repurchase 31.478,500 shares

Gelonghui Finance ·  May 6 04:04

Gelonghui, May 6, 丨 Haixiang Pharmaceutical (002099.SZ) announced that as of May 1, 2024, the repurchase period has expired, and the share repurchase plan has been implemented. The actual repurchase range of this repurchase was from February 5, 2024 to April 30, 2024. The company actually repurchased 31.478,500 shares of the company's total share capital, and the highest transaction price was 6.37 yuan/share. The minimum transaction price was 3.98 yuan/share, and the total transaction amount was 151 million yuan (including transaction fees).

Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more
    Write a comment